Tickwind
HoyOportunidadesMercadosChat con IA
ES
Iniciar sesiónRegistrarse
Tickwind

Lee cada tick. Ve hacia dónde sopla el mercado.

  • XInglés
  • TelegramChino
  • BoletínInglés

Producto

  • Mercados
  • Zonas temáticas
  • Todas las acciones
  • Comparar
  • Acciones en tendencia
  • Oportunidades
  • Noticias
  • Discusión
  • Lista de seguimiento
  • Novedades

Cuenta

  • Ajustes
  • Boletín
  • Para prensa e investigación
  • Servidor MCP
  • Contacto
  • Iniciar sesión
  • Registrarse
MercadosZonas temáticasTodas las accionesCompararAcciones en tendenciaOportunidadesNoticiasDiscusiónLista de seguimientoNovedadesAjustesBoletínPara prensa e investigaciónServidor MCPContactoIniciar sesiónRegistrarse

© 2026 Tickwind. No es asesoría de inversión.

Hecho para el inversor curioso.

Home/BHVN/vs peers

BHVNBiohaven Ltd.vs its industry peers

A metric-by-metric comparison of Biohaven Ltd. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.

Full peer comparison
Peers: same SEC industry
EmpresaMarket capP/E (TTM)P/BP/SRevenue growth (YoY)Earnings growth (YoY)EBIT marginROEROICPiotroski F1y total returnDividend yield
BHVNBiohaven Ltd.Esta$2.4B#7————12.7%#5——————
BHCBausch Health Companies Inc.$3.0B#1——0.3x#16.7%#7441.3%#117.7%#3—3.7%#3—33.2%#311.7%#1
IDYAIDEAYA Biosciences, Inc.$3.0B#2—2.8x#413.8x#53024.4%#258.6%#2-72.8%#5-10.4%#3——-0.2%#5—
VRDNViridian Therapeutics, Inc.\DE$2.8B#3—4.3x#640.2x#823359.9%#1-26.9%#9-512.9%#9-51.7%#8-54.5%#5———
NRIXNurix Therapeutics, Inc.$2.8B#410.6x#12.9x#533.6x#754.0%#4-36.6%#10-340.2%#8-27.3%#6————
MBXMBX Biosciences, Inc.$2.7B#5—6.5x#10——-40.5%#11—-21.2%#5——166.7%#1—
RCUSArcus Biosciences, Inc.$2.4B#6—5.2x#873.0x#10-35.3%#11-24.7%#8-1169.7%#10-76.1%#11-93.0%#8—-7.0%#6—
PBH$2.3B#813.9x#31.2x#22.2x#3-4.3%#9-11.3%#728.4%#19.9%#25.9%#24#1——
IMNMImmunome Inc.$2.3B#9—4.4x#7332.7x#11-23.2%#1027.5%#4-3228.8%#11-40.4%#7-72.8%#7—19.4%#4—
VERA$2.2B#10—5.4x#9——-96.9%#12—-73.5%#10-72.7%#6———
PVLA$2.2B#11—10.2x#1151.6x#965.3%#3-139.3%#13-90.2%#7-19.2%#4————
PRGO$2.2B#12—0.9x#10.5x#2-2.8%#8-729.7%#14-26.4%#4-56.7%#9-20.9%#44#1—7.3%#2
HRMY$2.2B#1312.0x#22.2x#32.5x#421.5%#69.1%#624.0%#215.9%#125.5%#14#1——
ZYME$2.1B#14—26.6x#1220.2x#638.9%#533.9%#3-87.3%#6-100.9%#12——59.5%#2—

Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-04.

Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice

BHVN's peers

BHCIDYAVRDNNRIXMBXRCUSPBHIMNMVERAPVLAPRGOHRMYZYME
← BHVN overview